Previous studies have demonstrated the NF-κB-inhibitory effect of GpS in activated macrophages and our group has also shown that GpS is an effective inhibitor of STAT3 in the intestinal epithelium and polyps of CRC ApcMin/+ mice [31, 32]. The gene discussed is NFKB1; the disease is colorectal carcinoma.